BRAF-V600E degrader (Cullgen)

N/A

Report date: 2025/03/14 16:29:47
NME

Base Information

Drug NameBRAF-V600E degrader (Cullgen)
Drug Alias Namethalidomide-based heterobifunctional small molecule degraders (Cullgen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCullgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesCullgen Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A